Organon & Co. (OGN) News

Organon & Co. (OGN): $33.08

-0.64 (-1.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter OGN News Items

OGN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OGN News Highlights

  • OGN's 30 day story count now stands at 9.
  • Over the past 16 days, the trend for OGN's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
  • DOW and MRK are the most mentioned tickers in articles about OGN.

Latest OGN News From Around the Web

Below are the latest news stories about Organon & Co that investors may wish to consider to help them evaluate OGN as an investment opportunity.

3 Reasons To Buy Organon Stock, Says BofA Analyst

Organon & Co (NYSE: OGN ), which has recently spun-off from Merck & Co., Inc. (NYSE: MRK ), has inherited a global business across three segments, namely Womens Health, Legacy and Biosimilars brands, according to BofA Securities. The Organon Analyst: Jason Gerberry initiated coverage of Organon with a Buy rating and a price target of $43. The Organon Thesis: The company has a strong management team, with experience in working in the Big Pharma segment, Full story available on Benzinga.com

Benzinga | September 1, 2021

Organon To Present at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference

JERSEY CITY, N.J., September 01, 2021--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Morgan Stanley’s 19th Annual Global Healthcare Virtual Conference on Monday, September 13, 2021 at 9:30 a.m. EDT.

Yahoo | September 1, 2021

Organon To Present at Citi’s 16th Annual BioPharma Virtual Conference

JERSEY CITY, N.J., September 01, 2021--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in a fireside chat at Citi’s 16th Annual BioPharma Virtual Conference on Friday, September 10, 2021 at 9:45 a.m. EDT.

Yahoo | September 1, 2021

Warren Buffett is hanging on to these stocks for stable income — you could too

Warren Buffett still likes these high-yield plays — maybe you should too.

Yahoo | August 31, 2021

Top Healthcare Stocks for September 2021

These are the healthcare stocks with the best value, fastest growth, and most momentum for September 2021.

Yahoo | August 25, 2021

Dow Jones Immediately, Shares Stoop As Markets Await Powell Feedback; Q2 Information Sinks House Depot, Lifts Walmart; Tesla Heads Decrease

The Dow industrials took a fast 350-point dive Tuesday, as earnings information, weak retail gross sales information and new rules in China helped drive early declines Earnings information lifted IBD 50 inventory Sea Ltd. Warren Buffets Berkshire Hathaway boosted Organon and Krogers. Retailers acquired prime billing on the Dow Jones at present, as Walmart and [] The post Dow Jones Immediately, Shares Stoop As Markets Await Powell Feedback; Q2 Information Sinks House Depot, Lifts Walmart; Tesla Heads Decrease appeared first on Business News .

Business Blog Daddy | August 17, 2021

Buffetts Berkshire sheds Axalta, Biogen; buys Organon

Warren Buffetts Berkshire Hathaway Inc said on Monday it has shed its holdings of drugmaker Biogen Inc and paint maker Axalta Coating Systems Ltd , while taking a new stake in another pharmaceutical company, Organon & Co. The changes were disclosed in a regulatory filing detailing Berkshires U.S.-listed holdings as of June 30. Berkshire has []

Financial Post | August 16, 2021

Warren Buffetts Berkshire pares drug holdings, sheds Axalta, Biogen

Firm reports new stake in a Merck & Co spinoff, Organon & Co.

The Globe and Mail | August 16, 2021

Is Organon & Co. (NYSE:OGN) Popular Amongst Institutions?

The big shareholder groups in Organon & Co. ( NYSE:OGN ) have power over the company. Institutions will often hold...

Yahoo | August 16, 2021

Organon Reports Results for the Second Quarter Ended June 30, 2021 and Announces Inaugural Dividend

JERSEY CITY, N.J., August 12, 2021--Organon (NYSE: OGN) (the "company"), today announced its results for the second quarter and year to date ended June 30, 2021 and affirmed its full year 2021 financial guidance.

Yahoo | August 12, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.0005 seconds.